Mobia Medical Secures CMS Proposed 2027 Reimbursement for Vivistim
AUSTIN, Texas, July 2, 2026 Mobia Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has...
CMS
Advertisement
Gilead’s Once-Weekly Yeztugo Accepted by FDA for HIV Prevention Review
FOSTER CITY, Calif., June 16, 2026 Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has...
Halia Therapeutics Secures FDA Fast Track for Ofirnoflast
LEHI, Utah, June 15, 2026 Halia Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted...
Halozyme Reaffirms Long-Term Royalty Growth Despite Proposed Medicare Pricing Changes
SAN DIEGO, June 15, 2026 Halozyme Therapeutics, Inc. has confirmed that it expects zero to minimal impact on royalty...
Oracle Health Drives Interoperability, Digital Check-In
AUSTIN, Texas, April 20, 2026 Oracle Health announced a major milestone in healthcare interoperability and digital transformation, achieving designation...
Advertisements
Johnson & Johnson INLEXZO Gets J-Code for Cancer Access
RARITAN, N.J., USA — April 1, 2026 Johnson & Johnson announced that its innovative bladder cancer therapy INLEXZO™ (gemcitabine...
OneOncology Secures CMS QCDR Approval for 2026
February 25, 2026 – Nashville, Tennessee, USA OneOncology has announced that its Oncology Quality Hub has been officially approved...
Verana Health Expands MIPS Advisory to Boost Clinical Compliance
SAN FRANCISCO, Calif., Oct. 7, 2025 — Verana Health announced the expansion of its MIPS Advisory Services, offering enhanced...
Advertisement
